Autism Protocol
for Hyperbarics
He Has An
Autistic Grandson.
You can read
more about that below.
Congressional Testimony
"Announcement
of a New Treatment Protocol for Autism Spectrum Disorders and other
Neurological Impairments"
The International Hyperbaric Medical Association Foundation
Paul Harch, M.D. President
Before the Government Reform & Oversight Hearing --Subcommittee on
Wellness & Human Rights
Entitled "Autism Spectrum Disorders: An Update of Federal Government
Initiatives and Revolutionary New Treatments of Neurodevelopmental
Diseases "
United States House of Representatives
May 6, 2004, 2:00PM
International Hyperbaric Medical Association Foundation
46 Draper Circle, Suite B Stafford, Virginia 22554-4754
Office: 540-720-4255 Fax: 540-720-2486
P. Harch MD May 6, 2004 Testimony - 2 - TESTIMONY OF PAUL G. HARCH,
M.D
MAY 6, 2004
GOVERNMENT OVERSIGHT COMMITTEE
SUBCOMMITTEE ON HEALTH AFFAIRS
CHAIRMAN, DAN BURTON
Chairman Burton
and distinguished members of the Subcommittee, thank you for the
opportunity to present the findings of my research and practice on
the hyperbaric oxygen therapy (HBOT) treatment of children with
autism, autism spectrum disorders, and persistent developmental
delay. These findings will hopefully be encouraging, and when
coupled with the testimony of the other physicians, exciting.
Together we would like to suggest a new approach to the acute
treatment of the insults that predispose to these disorders as well
as the delayed treatment when the disorder is well established.
The key
announcement today is about an evidence-based medicine study that
will combine two treatments that have been found to be effective in
treating autistic children mercury detoxification and hyperbaric
oxygen. The IHMA Foundation is collaborating with the American Board
of Clinical Metal Toxicology (ABCMT) under the supervision of the
Oklahoma University Health Sciences Center on this revolutionary new
treatment for autism. The Institutional Review Board (IRB) approved
protocol will use transdermal DMPS chelation and hyperbaric oxygen.
Transdermal DMPS, with absorption through the skin, has a number of
advantages over oral, IV, or injected chelation which enhances its
effectiveness. After several months on the transdermal chelator,
hyperbaric oxygen treatments will be administered using the
Neubauer-Harch dive protocol, and then after another time period has
elapsed, the second set of HBOT treatments will be administered.
The transdermal
chelator will continue to be used until the next set of hyperbaric
treatments is applied. It is expected that the combination of the
two therapies will double the effectiveness of the chelator and
allow the hyperbaric oxygen to cause permanent neural recovery. All
patients enrolled in the study will have extensive before and after
neurological scans and neuropsych testing performed by independent
observers, and all will receive real treatment. After all, no
placebo group is necessary when you know the outcome for untreated
patients. By definition neither oxygen or the chelator can be a
placebo since both have known effects as a drug.
Rashid Buttar,
DO, whom you just heard testify, developed this transdermal chelator
and has had excellent success with the treatment of over 40
patients. Dr. Buttar is one of the Board members of the IHMA
Foundation and also Vice Chairman of the ABCMT.
Dr. Buttar's
treatment has clear and demonstrable effects as we can all see here
today. The older a child is, however, the more difficulty they have
clearing their brain. Bob Nash, MD, Chairman of the ABCMT is a
neurologist and certified in chelation and hyperbaric medicine. He
explained that you often have to 'pound away' with chelation at
patients for a long time because the neurons are stunned and do not
have proper metabolism, so they cannot clear the heavy metals and
cells cannot pick up the chelate. The addition, hyperbaric
treatments kick start the neurons and 'light them up' so when the
chelator is present it becomes easier to eliminate the heavy metals
that are preventing the neuron's normal function.
We expect this
combination of therapies to shorten the time that these patients
will have to be treated, returning them to more normal status more
quickly, and also result in a more complete recovery than if they
had each individual treatment by itself. Dr. Nash came to this
conclusion when he examined the brain scans of several of my
patients where I used a scan-dive-scan diagnostic to determine
recoverable brain tissue. I will cover this evidence in just a
moment.
This treatment is available now on a limited basis.
Due to
collaboration between the IHMA Foundation, Oklahoma University
Health Sciences Center, and the treating physicians who have
developed this therapy, we expect it to be available in many
locations across the nation later this year. After that we expect it
to become the standard of care for all autistic children,
nation-wide.
Consider that
Wisconsin is spending $30,000 in tax dollars on each autistic child
per year right now in a special "training program," with a 3 year
cost of $90,000 that still leaves children autistic at the end. The
outcome is some behavioral improvement. Our treatment program is
expected to cost about $20,000 and result in children who can
function normally. We expect the states to adopt this protocol
quickly and help fund the general treatment for these children once
they see the results of this study.
Amongst the
nearly 400 brain injured patients that I have evaluated and treated
in the past 15 years with HBOT and SPECT are approximately 20
children with Autism, Autism Spectrum Disorders, and Persistent
Developmental Delay. When evaluated with the sequence of SPECT, one
HBOT, repeat SPECT I have found that these children's' brain blood
flow pattern improves and predicts permanent improvement with
additional HBOT similar to the boxers, divers, and patients with
other diagnoses. This change in blood flow after one HBOT is clearly
demonstrated in the 8 year old Persistent Developmental Delay/Autism
patient I presented to Chairman Regula and which I present again
today. His three dimensional brain scans are seen in the attached
Case 1.
Chambers
To Choose From
Click on
the Picture to Go To the Detailed Page
Free Shipping on all chambers w/in the USA
Balanced Health Today
355 Hukililke Street ( suite 206)
Kahului, Hi 96732
//www.BalancedHealthToday.com
info@BalancedHealthToday.com
888.449.0552
